Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MKNK1 | Q9BUB5 | 3/20 | 0.49 |
| ▸ | MKNK2 | Q9HBH9 | 3/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 5/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.45 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.45 |
| ▸ | KIF11 | P52732 | 1/20 | 0.45 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10960411 | 0.91 | CYP2A6 (0.50) | CYP2A6ALDH1A1CYP1A2CYP3A4MKNK1 | |
| SCHEMBL10022104 | 0.87 | MEN1 (0.47) | CYP2A6ALDH1A1CYP1A2CYP3A4MKNK1 | |
| SCHEMBL10022099 | 0.85 | CYP2A6 (0.47) | CYP2A6ALDH1A1CYP1A2CYP3A4PTGS2 | |
| SCHEMBL10022120 | 0.82 | NOTUM (0.46) | ALDH1A1CYP1A2CYP3A4CYP11B2CYP19A1 | |
| SCHEMBL8758641 | 0.82 | ALDH1A1 (0.43) | CYP2A6ALDH1A1CYP1A2CYP3A4TSHR | |
| SCHEMBL29266807 | 0.82 | CYP2A6 (0.68) | CYP2A6ALDH1A1CYP1A2CYP3A4MKNK1 | |
| Biphenyl SCHEMBL28948287 | 0.80 | ALDH1A1 (0.44) | CYP2A6ALDH1A1TSHR | |
| SCHEMBL2467050 | 0.80 | ALDH1A1 (0.48) | CYP2A6ALDH1A1TSHR | |
| SCHEMBL1878224 | 0.78 | NOTUM (0.44) | ALDH1A1CYP1A2CYP3A4CYP11B2CYP19A1 | |
| SCHEMBL551427 | 0.78 | PTGS2 (0.54) | CYP2A6ALDH1A1CYP1A2CYP3A4MKNK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110642-B2 | Synthesis of vinylphenylpyridine and living anionic polymerization | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2012-02-07 | — | — | US | disclosed |
| US-8110642-B2 | Synthesis of vinylphenylpyridine and living anionic polymerization | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2012-02-07 | — | — | US | disclosed |
| US-20090105416-A1 | Synthesis of Vinylphenylpyridine and Living Anionic Polymerization | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-04-23 | — | — | US | disclosed |
| US-20090105416-A1 | Synthesis of Vinylphenylpyridine and Living Anionic Polymerization | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-04-23 | — | — | US | disclosed |
| WO-2007129810-A1 | SYNTHESIS OF VINYLPHENYLPYRIDINE AND LIVING ANIONIC POLYMERIZATION | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2007-11-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105416-A1 | Synthesis of Vinylphenylpyridine and Living Anionic Polymerization | PBRM1, MVD, PCBP1 | CYP2A6 1144/4885ALDH1A1 865/4885CYP1A2 302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.